Excerpt of story provided by Crain's Cleveland Business
Written by Chuck Soder
AcelleRX Therapeutics Inc., a Cleveland Clinic spinoff company, has received a $6.9 million investment that will finance the first clinical trial of its cardiovascular stem cell therapy.
Triathlon Medical Ventures of Cincinnati led the round. Other investors include Early Stage Partners of Cleveland, Fletcher Spaght Ventures of Boston, Reservoir Venture Partners of Columbus, Blue Chip Venture Co. of Cincinnati, JumpStart Inc. of Cleveland and North Coast Angel Fund of Mayfield Heights...
Read the complete article.
*To view articles two weeks old or less, you must have a print or digital subscription. Articles older than two weeks are free.*
JumpStart cannot be responsible for broken links on third party sites.